Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment

Previously, we detected circulating tumor DNA that contained two EGFR mutations (p.L858R and exon19 del) in plasma of patients with late-stage non–small-cell lung carcinoma (NSCLC) using the electric field–induced release and measurement (EFIRM) platform. Our aim was to determine whether EFIRM techn...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Mol Diagn
Auteurs principaux: Wei, Fang, Strom, Charles M., Cheng, Jordan, Lin, Chien-Chung, Hsu, Ching-Yun, Soo Hoo, Guy W., Chia, David, Kim, Yong, Li, Feng, Elashoff, David, Grognan, Tristan, Tu, Michael, Liao, Wei, Xian, Rena, Grody, Wayne W., Su, Wu-Chou, Wong, David T.W.
Format: Artigo
Langue:Inglês
Publié: American Society for Investigative Pathology 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6198245/
https://ncbi.nlm.nih.gov/pubmed/30309763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2018.06.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires